Skip to main content

CORRECTION article

Front. Immunol., 04 January 2024
Sec. Viral Immunology
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1344990

Corrigendum: Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis

This article is a correction to:

  1. Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis

    1. Read original article
Cong-wen Yang&#x;Cong-wen Yang1†Ru-dong Chen&#x;Ru-dong Chen2†Qing-run ZhuQing-run Zhu2Shi-jie Han*&#x;Shi-jie Han2*‡Ming-jie Kuang*&#x;Ming-jie Kuang2*‡
  • 1Department of Neurosurgery, Weifang Medical University, Weifang, China
  • 2Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

A Corrigendum on
Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis

by Yang C-w, Chen R-d, Zhu Q-r, Han S-j and Kuang M-j (2022) Front. Immunol. 13:923286. doi: 10.3389/fimmu.2022.923286

Incorrect affiliation

In the published article, there was an error in the second affiliation. Instead of “Department of Spinal Surgery, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China”, it should be “Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: COVID-19, umbilical cord mesenchymal stromal cells (UC-MSCs), immunomodulation, adverse events and severe adverse events, the Mortality rate

Citation: Yang C-w, Chen R-d, Zhu Q-r, Han S-j and Kuang M-j (2024) Corrigendum: Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis. Front. Immunol. 14:1344990. doi: 10.3389/fimmu.2023.1344990

Received: 27 November 2023; Accepted: 28 November 2023;
Published: 04 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Yang, Chen, Zhu, Han and Kuang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ming-jie Kuang, c2VhZ3VsbGttakAxMjYuY29t; Shi-jie Han, aGFuc2hpamllQHNkZm11LmVkdS5jbg==

†These authors have contributed equally to this work and share the first authorship

‡These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.